Press release content from Business Wire. The AP news staff was not involved in its creation. BIONIK Laboratories Reports Fiscal 2021 Q3 Financial Results February 11, 2021 GMT TORONTO & BOSTON--(BUSINESS WIRE)--Feb 11, 2021-- BIONIK Laboratories Corp. (OTCQB:BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today reported financial results for its third quarter of fiscal year 2021, ended December 31, 2020. ADVERTISEMENT “We believe we have made tremendous progress in the most recent quarter in the further digitalization of our company, highlighted by a 14% growth in our revenue from the prior year period. This growth is driven by our InMotion Connect ® digital solutions sales from one of our strategic partners, and a key shipment to our distribution partner in South Korea, as we continue to penetrate the Asian markets,” said Dr. Eric Dusseux, Chief Executive Officer, BIONIK. “Our R&D team continues to see positive results with the data we are collecting in the cloud from our technology, allowing us to develop further InMotion Connect ® digital solutions and explore new AI solutions.”